- Home
- IBIO vs MKTW Comparison
IBIO vs MKTW Comparison
Compare IBIO & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBIO
- MKTW
- Stock Information
- Founded
- IBIO 2008
- MKTW 1999
- Country
- IBIO United States
- MKTW United States
- Employees
- IBIO N/A
- MKTW N/A
- Industry
- IBIO Biotechnology: Pharmaceutical Preparations
- MKTW Computer Software: Prepackaged Software
- Sector
- IBIO Health Care
- MKTW Technology
- Exchange
- IBIO Nasdaq
- MKTW Nasdaq
- Market Cap
- IBIO 24.3M
- MKTW 29.1M
- IPO Year
- IBIO N/A
- MKTW N/A
- Fundamental
- Price
- IBIO $0.76
- MKTW $13.55
- Analyst Decision
- IBIO Strong Buy
- MKTW
- Analyst Count
- IBIO 3
- MKTW 0
- Target Price
- IBIO $4.87
- MKTW N/A
- AVG Volume (30 Days)
- IBIO 1.2M
- MKTW 50.7K
- Earning Date
- IBIO 05-12-2025
- MKTW 05-14-2025
- Dividend Yield
- IBIO N/A
- MKTW 3.29%
- EPS Growth
- IBIO N/A
- MKTW 260.00
- EPS
- IBIO N/A
- MKTW 3.60
- Revenue
- IBIO $375,000.00
- MKTW $408,701,000.00
- Revenue This Year
- IBIO $36.00
- MKTW N/A
- Revenue Next Year
- IBIO $33.33
- MKTW $15.73
- P/E Ratio
- IBIO N/A
- MKTW $3.85
- Revenue Growth
- IBIO 650.00
- MKTW N/A
- 52 Week Low
- IBIO $0.87
- MKTW $9.08
- 52 Week High
- IBIO $6.89
- MKTW $34.60
- Technical
- Relative Strength Index (RSI)
- IBIO 19.10
- MKTW 61.74
- Support Level
- IBIO $0.64
- MKTW $12.76
- Resistance Level
- IBIO $1.00
- MKTW $14.53
- Average True Range (ATR)
- IBIO 0.32
- MKTW 1.34
- MACD
- IBIO -0.10
- MKTW 0.39
- Stochastic Oscillator
- IBIO 3.55
- MKTW 83.43
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.